# pazopanib

NDC: 13668-735
Generic name: pazopanib hydrochloride
Labeler / Manufacturer: Torrent Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250904

FDA application: ANDA219922

## Active ingredients

- PAZOPANIB HYDROCHLORIDE: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"13668-735"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=13668-735
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7235fad0-eb5b-4fdf-a362-c8c65c9bfe1d